Osteoporosis, postmenopausal women
Paladin Labs Inc.
Call for patient/clinician input open:
Call for patient/clinician input closed:
NOC Status at Filing:
Manufacturer Requested Reimbursement Criteria1:
For the treatment of osteoporosis in postmenopausal women at high risk of fracture or who have failed on other available osteoporosis therapy.
For the treatment of osteoporosis in postmenopausal women at high risk of fracture or who have failed or are intolerant to other available osteoporosis therapy.
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.